Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Ethnicity as an independent predictive factor for the results of computed tomography pulmonary angiography and ultrasonography of the lower limbs.

Liao S, McAnulty K, Lim C, Reeve P, Chang CL.

Intern Med J. 2016 Aug;46(8):942-5. doi: 10.1111/imj.13134.

PMID:
27241958
2.

Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.

Claussen C, Rausch AV, Lezius S, Amirkhosravi A, Davila M, Francis JL, Hisada YM, Mackman N, Bokemeyer C, Schmalfeldt B, Mahner S, Langer F.

Thromb Res. 2016 May;141:39-48. doi: 10.1016/j.thromres.2016.03.002.

PMID:
26967531
3.

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban-treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding.

Kline JA, Jimenez D, Courtney DM, Ianus J, Cao L, Lensing AW, Prins MH, Wells PS.

Acad Emerg Med. 2016 Feb;23(2):144-50. doi: 10.1111/acem.12865.

4.

ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.

Pépin M, Kleinjan A, Hajage D, Büller HR, Di Nisio M, Kamphuisen PW, Salomon L, Veyradier A, Stepanian A, Mahé I.

J Thromb Haemost. 2016 Feb;14(2):306-15. doi: 10.1111/jth.13205.

PMID:
26589836
5.

Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.

Nemeth B, van Adrichem RA, van Hylckama Vlieg A, Bucciarelli P, Martinelli I, Baglin T, Rosendaal FR, le Cessie S, Cannegieter SC.

PLoS Med. 2015 Nov 10;12(11):e1001899; discussion e1001899. doi: 10.1371/journal.pmed.1001899.

6.

Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists.

Di Nisio M, Ageno W, Rutjes AW, Pap AF, Büller HR.

Thromb Haemost. 2016 Jan;115(2):424-32. doi: 10.1160/TH15-06-0474.

PMID:
26511068
7.

Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis.

Tafur AJ, Dale G, Cherry M, Wren JD, Mansfield AS, Comp P, Rathbun S, Stoner JA.

Thromb Res. 2015 Dec;136(6):1120-5. doi: 10.1016/j.thromres.2015.10.004.

8.

Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients.

Bianconi D, Schuler A, Pausz C, Geroldinger A, Kaider A, Lenz HJ, Kornek G, Scheithauer W, Zielinski CC, Pabinger I, Ay C, Prager GW.

Thromb Res. 2015 Nov;136(5):865-9. doi: 10.1016/j.thromres.2015.08.010.

9.

Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.

Weingarz L, Schindewolf M, Schwonberg J, Hecking C, Wolf Z, Erbe M, Lindhoff-Last E, Linnemann B.

Vasa. 2015 Jul;44(4):313-23. doi: 10.1024/0301-1526/a000447.

PMID:
26314364
10.

Uncertain thrombophilia markers.

Franchini M, Martinelli I, Mannucci PM.

Thromb Haemost. 2016 Jan;115(1):25-30. doi: 10.1160/TH15-06-0478. Review.

PMID:
26271270
12.

Predictive value of markers of inflammation in the postthrombotic syndrome: a systematic review: inflammatory biomarkers and PTS.

Rabinovich A, Cohen JM, Kahn SR.

Thromb Res. 2015 Aug;136(2):289-97. doi: 10.1016/j.thromres.2015.06.024. Review.

PMID:
26139086
13.

Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.

Hillis C, Crowther MA.

Thromb Haemost. 2015 Jun;113(6):1193-202. doi: 10.1160/TH14-12-1036. Review. Erratum in: Thromb Haemost. 2015 Jul;114(1):210.

PMID:
25948149
14.

Clinical Course of Cerebral Venous Thrombosis in Adult Acute Lymphoblastic Leukemia.

Zuurbier SM, Lauw MN, Coutinho JM, Majoie CB, van der Holt B, Cornelissen JJ, Middeldorp S, Biemond BJ, Stam J.

J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1679-84. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.041.

PMID:
25934140
15.
16.

Of men and meals.

Beyer-Westendorf J, Siegert G.

J Thromb Haemost. 2015 Jun;13(6):943-5. doi: 10.1111/jth.12973.

PMID:
25880707
17.

Congestive heart failure is a risk factor for venous thromboembolism in bariatric surgery.

Haskins IN, Amdur R, Sarani B, Vaziri K.

Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1140-5. doi: 10.1016/j.soard.2014.12.020.

PMID:
25868833
18.

Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer.

Ades S, Kumar S, Alam M, Goodwin A, Weckstein D, Dugan M, Ashikaga T, Evans M, Verschraegen C, Holmes CE.

J Thromb Haemost. 2015 Jun;13(6):998-1003. doi: 10.1111/jth.12910.

PMID:
25809746
19.

Diagnosis of deep vein thrombosis, and prevention of deep vein thrombosis recurrence and the post-thrombotic syndrome in the primary care medicine setting anno 2014.

Michiels JJ, Michiels JM, Moossdorff W, Lao M, Maasland H, Palareti G.

World J Crit Care Med. 2015 Feb 4;4(1):29-39. doi: 10.5492/wjccm.v4.i1.29. Review.

20.

Cancer-associated thrombosis: an overview.

Elyamany G, Alzahrani AM, Bukhary E.

Clin Med Insights Oncol. 2014 Dec 4;8:129-37. doi: 10.4137/CMO.S18991. Review.

Items per page

Supplemental Content

Loading ...
Support Center